A letter dated Aug. 29, 2023 from the Department of Health and Human Services to Anne Milgram, of the Drug Enforcement Administration (DEA) was leaked to Bloomberg News. The letter calls for rescheduling marijuana as a Schedule III drug under the Controlled Substances Act. The DEA confirmed receipt of the letter to Bloomberg News and indicated that the department would now conduct its own review based on the recommendation. Marijuana is currently a Schedule I drug (grouped with heroin, LSD, and ecstasy). Schedule III drugs (like ketamine) may be obtained with a prescription.
Last updated on:
9/6/2023 |
Author: ProCon.org